Correction: Genitourinary syndrome of menopause

Anna Camille Moreno; Sabrina K Sikka; Holly L Thacker

Correction: Genitourinary syndrome of menopause

Cleve Clin J Med. 2018 Nov;85(11):860.

Authors

Anna Camille Moreno¹, Sabrina K Sikka¹, Holly L Thacker^{2

3}

Affiliations

¹ Specialized Women's Health Fellow, Center for Specialized Women's Health, Women's Health Institute, Cleveland Clinic, Cleveland, OH, USA.
² Director, Center for Specialized Women's Health, Department of Obstetrics and Gynecology, Women's Health Institute, Cleveland Clinic, Cleveland, OH, USA. thackeh@ccf.org.
³ Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.

PMID: 30395529

Abstract

In the article by A.C. Moreno, S.K. Sikka, and H.L. Thacker, Genitourinary syndrome of menopause in breast cancer survivors: Treatments are available, Cleve Clin J Med 2018; 85(10):760-766, doi:10.3949/ccjm.85a.17108, Table 2 incorrectly stated that prasterone is contraindicated in women with known or suspected breast cancer. This correction has been made online as follows. "Warning: Estrogen is a metabolite of prasterone; use of exogenous extrogen is contraindicated in women with known or suspected breast cancer; prasterone has not been studied in women with a history of breast cancer."

Publication types

Published Erratum